Update in cystic fibrosis 2008.
Ratjen
Felix
F
University of Toronto, Division of Respiratory Medicine, The Hospital for Sick Children, 555 University Avenue, Toronto ON M5G1X8, Canada. felix.ratjen@sickkids.ca.
D000584:Amiloride / Q000627:therapeutic use; D000818:Animals; D001424:Bacterial Infections / Q000188:drug therapy; D015415:Biomarkers / Q000032:analysis; D003550:Cystic Fibrosis / Q000188:drug therapy / Q000235:genetics / Q000503:physiopathology*; D019005:Cystic Fibrosis Transmembrane Conductance Regulator; D003845:Deoxycytosine Nucleotides / Q000627:therapeutic use; D018450:Disease Progression; D006801:Humans; D007249:Inflammation / Q000188:drug therapy / Q000503:physiopathology; D008168:Lung / Q000382:microbiology; D010069:Oxadiazoles / Q000627:therapeutic use; D012129:Respiratory Function Tests; D026941:Sodium Channel Blockers / Q000627:therapeutic use; D014529:Uridine / Q000031:analogs & derivatives / Q000627:therapeutic use
D015415:Biomarkers; C505032:CFTR protein, human; D003845:Deoxycytosine Nucleotides; D010069:Oxadiazoles; D026941:Sodium Channel Blockers; D019005:Cystic Fibrosis Transmembrane Conductance Regulator; D000584:Amiloride; C465279:denufosol tetrasodium; C515878:ataluren; D014529:Uridine